The same AI algorithms used to diagnose anomalies in CERN’s accelerator chain have the potential to detect brain pathologies such as strokes

[News from our partners] The partnership will assess particular aspects of the MARS 5x120 Extremity scanner.

This funding supports the commercialization of Terapet’s first product, Qualγscan and the development of new nuclear imaging products.

CERN, CHUV and THERYQ have signed an agreement for the development of a revolutionary FLASH radiotherapy device